Sensitivity of adult T‐cell leukaemia lymphoma cells to tumour necrosis factor‐related apoptosis‐inducing ligand
暂无分享,去创建一个
M. Tomonaga | S. Kamihira | H. Harasawa | K. Sugahara | H. Hasegawa | Y. Yamada | Y. Imaizumi | S. Ikeda | K. Murata | T. Tsuji | K. Tsuruda | N. Takasu | M. Masuda
[1] S. Shankar,et al. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[2] A. Ballestrero,et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Anticancer Drugs to Overcome Chemoresistance in Antiapoptotic Bcl-2 Family Members Expressing Jurkat Cells , 2004, Clinical Cancer Research.
[3] G. Cheng,et al. Human T-cell Leukemia Virus Type I Tax Protein Induces the Expression of Anti-Apoptotic Gene Bcl-xL in Human T-Cells through Nuclear Factor-κB and c-AMP Responsive Element Binding Protein Pathways , 2001, Virus Genes.
[4] Jian Kang,et al. Chemical sensitization and regulation of TRAIL‐induced apoptosis in a panel of B‐lymphocytic leukaemia cell lines , 2003, British journal of haematology.
[5] S. Gibson,et al. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia , 2003, Oncogene.
[6] G. Packham,et al. Regulation of tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐induced apoptosis in Burkitt's lymphoma cell lines , 2003, British journal of haematology.
[7] I. Jeremias,et al. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB , 2003, Oncogene.
[8] L. Foroni,et al. Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor‐related apoptosis‐inducing ligand , 2003, British journal of haematology.
[9] Hiroki Sato,et al. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells. , 2003, Blood.
[10] M. Tomonaga,et al. The Current Status of Therapy for Adult T-cell Leukaemia-Lymphoma in Japan , 2003, Leukemia & lymphoma.
[11] M. V. D. van den Brink,et al. Nature's TRAIL--on a path to cancer immunotherapy. , 2003, Immunity.
[12] G. Cohen,et al. Death receptors leave a caspase footprint that Smacs of XIAP , 2003, Cell Death and Differentiation.
[13] G. Cohen,et al. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia , 2002, Oncogene.
[14] S. Cory,et al. The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.
[15] M. Tomonaga,et al. Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-cell Leukemia Cells , 2002, International journal of hematology.
[16] A. Ashkenazi,et al. Targeting death and decoy receptors of the tumour-necrosis factor superfamily , 2002, Nature Reviews Cancer.
[17] Kenshi Hayashi,et al. Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. , 2002, Blood.
[18] P. Krammer,et al. Tumor Immunology , 2018, Medical Immunology.
[19] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[20] Michael Karin,et al. NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.
[21] P. Krammer,et al. FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.
[22] A. Österborg,et al. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D , 2001, Leukemia.
[23] G. Xiao,et al. NF-κB Signaling Pathway Governs TRAIL Gene Expression and Human T-cell Leukemia Virus-I Tax-induced T-cell Death* , 2001, The Journal of Biological Chemistry.
[24] A. Spencer,et al. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy , 2001, Leukemia.
[25] P. Richardson,et al. TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. , 2001, Blood.
[26] H. S. Kim,et al. Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. , 2001, Cancer research.
[27] M. Shin,et al. Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma , 2001, Oncogene.
[28] Yasuaki Yamada,et al. Soluble Fas (APO-1/CD95) Isoform in Adult T-Cell Leukemia , 2001, Leukemia & lymphoma.
[29] M. Yoshida,et al. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. , 2001, Annual review of immunology.
[30] B. Dörken,et al. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity , 2001, Leukemia.
[31] K. Bhalla,et al. Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. , 2000, Blood.
[32] U. Jaeger,et al. Expression of tumour necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) receptors and sensitivity to TRAIL‐induced apoptosis in primary B‐cell acute lymphoblastic leukaemia cells , 2000, British journal of haematology.
[33] J. Tschopp,et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.
[34] A. Hida,et al. Inhibition of Caspase Cascade by HTLV-I Tax Through Induction of NF-κB Nuclear Translocation , 1999 .
[35] M. Kannagi,et al. Induction of Bcl-xL Expression by Human T-Cell Leukemia Virus Type 1 Tax through NF-κB in Apoptosis-Resistant T-Cell Transfectants with Tax , 1999, Journal of Virology.
[36] S. Zhao,et al. Functional expression of TRAIL by lymphoid and myeloid tumour cells , 1999, British journal of haematology.
[37] D. Lawrence,et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.
[38] V. Dixit,et al. Apoptosis control by death and decoy receptors. , 1999, Current opinion in cell biology.
[39] M. Tomonaga,et al. Fas Gene Mutation in the Progression of Adult T Cell Leukemia , 1999, The Journal of experimental medicine.
[40] C. Rauch,et al. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.
[41] A. Hida,et al. Inhibition of caspase cascade by HTLV-I tax through induction of NF-kappaB nuclear translocation. , 1999, Blood.
[42] Junying Yuan,et al. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.
[43] Xiaodong Wang,et al. Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.
[44] M. Tomonaga,et al. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor alpha on ATL cells. , 1998, Blood.
[45] J C Reed,et al. IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases , 1998, The EMBO journal.
[46] M. Tomonaga,et al. Interleukin-15 (IL-15) Can Replace the IL-2 Signal in IL-2–Dependent Adult T-Cell Leukemia (ATL) Cell Lines: Expression of IL-15 Receptor α on ATL Cells , 1998 .
[47] S. Srinivasula,et al. Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.
[48] M. Tomonaga,et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. , 1996, Leukemia & lymphoma.
[49] C A Smith,et al. Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.
[50] Y. Ohtsuki,et al. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells , 1981, Nature.
[51] K. Miyamoto,et al. A novel T-cell line derived from adult T-cell leukemia. , 1980, Gan.
[52] E. Jaffe,et al. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. , 1980, Blood.